Roche Holding AG announced that effective 15 March 2023, the Board of Directors has appointed Thomas Schinecker, currently CEO of the Diagnostics Division, as CEO of Roche succeeding Severin Schwan. Thomas Schinecker holds a PhD in Molecular Biology and has been working for Roche in different leadership positions since 2003. He became CEO of the Diagnostics Division and a member of the Corporate Executive Committee in August 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
247.6 CHF | +0.73% | +2.06% | +1.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.27% | 225B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche Holding AG Announces Executive Changes